Revenue
$812.20M
Fiscal year ended 2026-06-30Operating income
$76.52M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30U S PHYSICAL THERAPY INC /NV (USPH) reported revenue of $812.20M and net income of $32.23M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from U S PHYSICAL THERAPY INC /NV’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $812.20M |
| Cost of revenue | Unavailable |
| Gross profit | $151.70M |
| Operating income | $76.52M |
| Net income | $32.23M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $67.45M |
| Income tax expense | $17.58M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $72.82M |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $24.89M |
| Total assets | $1.25B |
| Current assets | $139.68M |
| Total liabilities | $482.22M |
| Current liabilities | $109.91M |
| Total equity incl. NCI | $449.17M |
| Temporary (mezzanine) equity | $317.49M |
| Inventory | Unavailable |
| Accounts receivable | $69.60M |
| Goodwill | $716.54M |
| Long-term debt | $215.46M |
| Accounts payable | Unavailable |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $83.05M |
| Capital expenditures | Unavailable |
| Investing cash flow | -$63.59M |
| Financing cash flow | -$28.66M |
| Net change in cash | -$9.20M |
| Stock-based compensation | $9.86M |
| Common dividends paid | Unavailable |
| Common share repurchases | Unavailable |
| Depreciation & amortization | $21.75M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | Unavailable |
| Gross margin | 18.7% |
| Operating margin | 9.4% |
| FCF margin | Unavailable |
| SBC / revenue | 1.2% |
| Current ratio | 1.27x |
| Revenue YoY growth | 11.3% |
| Net margin | 4.0% |
| R&D / revenue | Unavailable |
| CapEx / revenue | Unavailable |
| Long-term debt / equity | 0.48x |
| Effective tax rate | 26.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USPH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-02-27View SEC filing
10-Q · Filed 2025-11-07View SEC filing
10-Q · Filed 2025-08-08View SEC filing
10-Q · Filed 2025-05-09View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.